Biomerica
BMRA
9 hedge funds and large institutions have $576K invested in Biomerica in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
29% more funds holding
Funds holding: 7 → 9 (+2)
7% more capital invested
Capital invested by funds: $539K → $576K (+$36.7K)
0.02% more ownership
Funds ownership: 0.2% → 0.22% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$81.4K |
| 2 |
BlackRock
New York
|
+$2.97K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.11K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$749 |
| 5 |
Barclays
London,
United Kingdom
|
+$210 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.3K |
BMRA Hedge Fund Activity: Q3 2018 in Review
9 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q3 2018, worth a combined $576K — up 6.8% from $539K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BMRA positions and 0 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $81.4K. The largest seller was UBS Group, cutting an estimated $3.3K.
- 9 institutional investors held Biomerica (BMRA) as of Q3 2018, up from 7 in Q2 2018.
- Funds reported $576K of Biomerica stock for Q3 2018, up 6.8% quarter-over-quarter.
- 2 funds opened new Biomerica positions in Q3 2018 and 0 closed out, a net change of +2 holders.
- The largest Biomerica buyer in Q3 2018 was Susquehanna International Group, an estimated $81.4K added.
- The largest Biomerica seller in Q3 2018 was UBS Group, an estimated $3.3K sold.
Based on aggregated 13F filings for Q3 2018.